PTSD Treatments for Sexual and Gender Minority Populations
This study is comparing two established therapies, Cognitive Processing Therapy and STAIR Narrative Therapy, to see how well they treat post-traumatic stress disorder (PTSD) in adults who identify as sexual and/or gender minorities (LGBTQIA+). The goal is to understand if these treatments reduce PTSD symptoms, improve quality of life, and lessen depression in this community. Researchers also want to see if factors like stress from discrimination or drug/alcohol use affect treatment outcomes, and if different groups within the LGBTQIA+ community respond differently. The study plans to enroll 400 participants and is currently unclear on its recruitment status.
- Study design
- This interventional study will compare two behavioral therapies in 400 participants. It aims to find out which treatment works best for LGBTQIA+ individuals.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months, with assessments at months 0 (baseline), 3, 6, and 12.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Annesa P Flentje, PhD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in Posttraumatic Stress Disorder (PTSD) Symptoms Measured by PTSD Checklist for DSM-5 (PCL-5)Months 0 (baseline), 3, 6, and 12
The PCL-5 is a validated measure of self-report DSM-5 symptoms of PTSD. The self-report rating scale is 0-4 for each symptom, with higher scores indicating greater symptom severity.